Filter Results:
(166)
Show Results For
- All HBS Web (206)
- Faculty Publications (140)
Show Results For
- All HBS Web (206)
- Faculty Publications (140)
Sort by
- September 1998
- Case
Monsanto's March into Biotechnology (C)
By: Dorothy A. Leonard and Robert Irwin
Supplements the (A) and (B) cases. View Details
Leonard, Dorothy A., and Robert Irwin. "Monsanto's March into Biotechnology (C)." Harvard Business School Case 699-021, September 1998.
- 17 Sep 2024
- HBS Case
The Climate Targets Leaders Need to Know as Regulations Loom
Michael Toffel, the Senator John Heinz Professor of Environmental Management at Harvard Business School. Roughly 42 percent of Fortune 500 companies said they’d reached an environmental target or committed to reaching one by 2030, an 11... View Details
Keywords: by Rachel Layne
- 31 May 2016
- HBS Case
Who Owns Space?
New Space sector: namely, to use it as a means of launching classroom discussion and research on the subtleties and challenges of the relationship between the public and private sectors. An associate professor of business administration... View Details
- 2022
- Chapter
Sustainability Science and Corporate Cleanup in Community Fields: The Translation, Resistance and Integration Process Model
By: P. Devereaux Jennings, Maggie Cascadden and Andrew J. Hoffman
Both practically and theoretically, the sustainability science and corporate operation perspectives often diverge. Overcoming this divergence requires some degree of engagement with organizational field members; not just negotiation, but on-the-ground process work to... View Details
Jennings, P. Devereaux, Maggie Cascadden, and Andrew J. Hoffman. "Sustainability Science and Corporate Cleanup in Community Fields: The Translation, Resistance and Integration Process Model." Chap. 12 in Handbook on the Business of Sustainability: The Organization, Implementation, and Practice of Sustainable Growth, edited by Gerard George, Martine Haas, Havovi Joshi, Anita McGahan, and Paul Tracey, 214–231. Edward Elgar Publishing, 2022.
- 2017
- Mimeo
Science for Society: Science and Technology Based Social Entrepreneurship
By: Tarun Khanna, Shashank Shah and Kundan Madireddy
This publication is an outcome of the team's research, engagement and interactions with over 25 science and technology-based social enterprises in India. It provides details on the research process, insightful outcomes and innovative impact.
Throughout the... View Details
Throughout the... View Details
Keywords: Social Entrepreneurship; Science-Based Business; Information Technology; Business and Community Relations; India
Khanna, Tarun, Shashank Shah, and Kundan Madireddy. "Science for Society: Science and Technology Based Social Entrepreneurship." Harvard University South Asia Institute, 2017. Mimeo. (This publication is an outcome of a grant from the Tata Trusts.)
- November 2014
- Teaching Note
Houston We Have a Problem: NASA and Open Innovation (A) and (B)
By: Michael L. Tushman, Hila Lifshitz-Assaf and Kerry Herman
- November 1983 (Revised May 1984)
- Case
SSS (Scientific Systems Services)
By: Howard H. Stevenson and Michael J. Roberts
Keywords: Science-Based Business
Stevenson, Howard H., and Michael J. Roberts. "SSS (Scientific Systems Services)." Harvard Business School Case 384-129, November 1983. (Revised May 1984.)
- 1999
- Chapter
The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change
By: Rebecca Henderson, Gary P. Pisano and Luigi Orsenigo
Keywords: Science-Based Business; Organizational Change and Adaptation; Transformation; Pharmaceutical Industry
Henderson, Rebecca, Gary P. Pisano, and Luigi Orsenigo. "The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change." In Sources of Industrial Leadership: Studies of Seven Industries, edited by David Mowery and Richard Nelson. Cambridge University Press, 1999.
- December 2008 (Revised January 2011)
- Case
Arcadia Biosciences: Seeds of Change
By: Arthur A. Daemmrich, Forest L. Reinhardt and Mary Louise Shelman
Arcadia Biosciences is an entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September 2008. The company... View Details
Keywords: Business Startups; Entrepreneurship; Growth and Development Strategy; Environmental Sustainability; Science-Based Business; Climate Change; Agriculture and Agribusiness Industry; Biotechnology Industry; China; India; California
Daemmrich, Arthur A., Forest L. Reinhardt, and Mary Louise Shelman. "Arcadia Biosciences: Seeds of Change." Harvard Business School Case 709-019, December 2008. (Revised January 2011.)
- 1992
- Chapter
Issues of Participation and Rights Allocation in Tradeable Permits Systems to Reduce Greenhouse Gas Emissions
By: James K. Sebenius and Michael Grubb
Keywords: Corporate Social Responsibility and Impact; Climate Change; Pollutants; Science-Based Business
Sebenius, James K., and Michael Grubb. "Issues of Participation and Rights Allocation in Tradeable Permits Systems to Reduce Greenhouse Gas Emissions." In Tradeable Permits to Reduce Greenhouse Gases, edited by Jan Corfee, 181–222. Paris: Organisation for Economic Co-operation and Development (OECD), 1992.
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- 2001
- Chapter
Transforming Life, Transforming Business: The Life Science Revolution
By: Juan Enriquez and Ray A. Goldberg
Keywords: Science-Based Business; Organizational Change and Adaptation; Human Needs; Welfare; Transformation
Enriquez, Juan, and Ray A. Goldberg. "Transforming Life, Transforming Business: The Life Science Revolution." In The Digital Enterprise: How To Reshape Your Business For A Connected World, edited by Nicholas G. Carr. Boston: Harvard Business School Press, 2001.
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
article, “Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting,” is co-authored by Harvard Business School Professor Karim R. Lakhani and seven colleagues with expertise in radiation... View Details
- 2010
- Working Paper
From Bench to Board: Gender Differences in University Scientists' Participation in Commercial Science
This paper examines gender differences in the participation of university life science faculty in commercial science. Based on theory and field interviews, we develop hypotheses regarding how scientists' productivity, co-authorship networks, and institutional... View Details
Keywords: Business Startups; For-Profit Firms; Gender Characteristics; Higher Education; Entrepreneurship; Governing and Advisory Boards; Science-Based Business; Nonprofit Organizations; Biotechnology Industry
Ding, Waverly W., Fiona Murray, and Toby E. Stuart. "From Bench to Board: Gender Differences in University Scientists' Participation in Commercial Science." Harvard Business School Working Paper, No. 11-014, August 2010.
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- June 2011 (Revised October 2013)
- Case
Gene Patents (A)
By: Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Science-Based Business; Biotechnology Industry; United States
Hamermesh, Richard, David Kiron, and Phillip Andrews. "Gene Patents (A)." Harvard Business School Case 811-089, June 2011. (Revised October 2013.)
- June 2019
- Teaching Note
Zebra Medical Vision
By: Shane Greenstein and Sarah Gulick
Teaching note is meant to accompany Zebra Medical Vision case, which offers a look at a company’s decisions as a small startup competing with other startups and major technology companies. It also demonstrates the challenges faced by a machine learning company working... View Details
- October 2012
- Teaching Plan
Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech (TP)
By: Robert F. Higgins
This is the teaching note related to HBS case 808005. In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates... View Details
Keywords: Venture Philanthropy; Biotechnology; Funding Philanthropy Venture; Cystic Fibrosis; Foundations; Pharmaceuticals; Mergers and Acquisitions; For-Profit Firms; Venture Capital; Philanthropy and Charitable Giving; Science-Based Business; Nonprofit Organizations; Pharmaceutical Industry; Biotechnology Industry; United States; San Diego
- 20 Apr 2010
- First Look
First Look: April 20
invisible hand of markets increasingly governs them. An assessment of this form of governance against the requirements of science-based businesses suggests a gap and a need for organizational innovation.... View Details
Keywords: Martha Lagace